1 Group I metabotropic glutamate receptors (mGluRs) are thought to be important modulators of neuronal function in the superior colliculus (SC). Here, we investigated the pharmacology and signalling mechanisms underlying group I mGluR-mediated inhibition of neuronal excitability and synaptic transmission in the rat SC slice. 2 The group I agonist (RS)-3,5-dihydroxyphenylglycine (DHPG) potently depressed synaptically evoked excitatory postsynaptic potentials (EPSPs), currents (EPSCs), and action potentials in a dosedependent manner (IC 50 : 6.3 mM). This was strongly reduced by the broad-spectrum antagonist ( þ )-alpha-methyl-4-carboxyphenylglycine (MCPG, 1 mM, B95% reduction), by the mGluR1 antagonist LY367385 (100 mM, B80% reduction) but not by the mGluR5 antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP, 1 -100 mM). 3 The putative mGluR5-specific agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG, 500 mM) also inhibited EPSPs. Interestingly, CHPG's actions were not blocked by MPEP, but LY367385 (100 mM) reduced the effect of CHPG by 50%. 4 Inhibition induced by DHPG was independent of phospholipase C (PLC)/protein kinase C pathways, and did not require intact intracellular Ca 2 þ stores. It was not abolished but enhanced by the GABA A antagonist bicuculline (5 mM), suggesting that DHPG's action was not due to facilitated inhibition or changes in neuronal network activity. 5 The K þ channel antagonist 4-aminopyridine (4-AP, 50 -100 mM) converted the inhibitory effect of DHPG into facilitation. Paired-pulse depression was strongly reduced by DHPG, an effect that was also prevented by 4-AP. 6 Our data indicate that group I agonists regulate transmitter release, presumably via an autoreceptor in the SC. This receptor may be involved in adaptation to repetitive stimulation via a non-PLC mediated pathway.